Upcoming miRNA Conferences
- Events on January 31, 2014
- Keystone Conference - RNA SilencingStarts: January 31, 2014Ends: February 6, 2014 - 12:00 amDescription: Small regulatory RNAs have been implicated in virtually every developmental process and have key impacts on pathological pathways. Over the last 15 years, the field has rapidly discovered novel types of small RNAs and their associated silencing machineries in diverse species. Major gaps remain, however, in our understanding of the function and the molecular mechanisms of the diverse array of RNA silencing pathways. This meeting has been playing a central role in the field of small RNA silencing by mixing and synergizing expertise from diverse academic backgrounds. Since the beginning, it serves as an annual forum for researchers working on many different biological systems ranging from bacteria to plants and humans. The 2014 meeting will adhere to this tradition and puts an additional emphasis on translational research and therapeutics development, as well as emerging resources and technologies.
- Events on February 24, 2014
- Next Generation Sequencing: Research to ClinicStarts: February 24, 2014Ends: February 26, 2014 - 12:00 amDescription: Not strictly miRNA but since NGS had become the main tool for miRNA discovery it is included here.
In this conference, there are presentations and panel discussions focusing on sample-preparation for NGS, NGS instrumentation, NGS data analysis/big data, and most-importantly the universe of applications being developed for the use of NGS in the discovery and interrogation of biomarkers, especially in oncology. As NGS permeates the cancer biomarker realm and cost of NGS declines, there is the opportunity and hope to deploy NGS as a means to personalize cancer diagnostics and therapeutics.
Front-end Sample Preparation for NGS
Informatics and Data Handling/Analysis
- NGS Big Data Handling
New Technology Development in NGS
- Instrumentation Platforms
- Reagent Offerings
NGS for Clinical Testing
- NGS in Non-Invasive Prenatal Testing (NIPT)
- Oncology Space and the Penetrance of NGS in Cancer Mutation Discovery
- Regulatory Landscape and Commercial Trends
NGS for Development of Therapeutic Antibodies and Vaccines
NGS on Rare Cells (such as Circulating Tumor Cells)
Research Trends and Applications of NGS
- Discovery of Mutations and Potential Biomarkers
- Epigenetic Modifications
- NGS on Exosomes, Extracellular Vesicles, and Biological Fluids
- Events on March 17, 2014
- microRNA as Biomarkers and DiagnosticsStarts: March 17, 2014Ends: March 19, 2014 - 12:00 amDescription: Recent research has shown microRNAs to have tremendous potential as non-invasive biomarkers for the diagnosis and prognosis of disease, monitoring of treatment, and patient stratification, with exosome-derived microRNAs of particular interest. Cambridge Healthtech Institute’s Tenth Annual microRNA as Biomarkers and Diagnostics will cover the latest developments in the use of microRNA in the early detection of disease for more effective treatment, monitoring tumor growth and disease progression, issues associated with microRNA measurement, and the potential for personalized medicine based on microRNA profile.
microRNA Biomarkers in Drug Development
microRNA Biomarkers as Cancer Diagnostics
microRNA as Disease Biomarkers
- Events on March 24, 2014
- Circulating Biomarkers 2014Starts: March 24, 2014Ends: March 26, 2014 - 12:00 amDescription: Our goal in this conference is to facilitate learning, exchange of information, foster collaborations, partnering, and networking, as well as bring together the vendors offering products and services to this research field; this conference includes an exhibit hall integrated with the conference sessions allowing vendors to connect with and reach effectively the target customers.
Finally, we will host "Exosome Night" yet again with beer, wine, and hors d'oeuvres--an excellent opportunity to network with your peers and forge partnerships, and for exhibits to connect with researchers and discuss their science and the new products in this space.
Circulating Tumor Cells (CTCs)
- Potential as Liquid Cancer Biomarkers
- Various Technologies for Capture and Interrogation
Deployment of Next-Generation Sequencing to Discover and Interrogate Biomarkers
Diagnostic Opportunities for Circulating Biomarkers [eg., Liquid Biopsies]
Epigenetic Modifications of Circulating DNA [eg., Methylated Genetic Elements]
Exosomes and Microvesicles
Extracellular RNAs [such as microRNAs]
New Technologies for Studying Exosomes/Microvesicles/Extracellular Vesicles
Non-invasive Prenatal Testing (NIPT) using Circulating Fetal DNA
Therapeutic Potential Applications of Exosomes